Related Experiment Videos
Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies
Leni von Bonsdorff1, Enni Lindeberg, Leila Sahlstedt
1Finnish Red Cross Blood Transfusion Service, Kivihaantie 7, FIN-00310 Helsinki, Finland. leni.bonsdorff@bts.redcross.fi
Clinical Chemistry
|January 24, 2002
Summary
A modified bleomycin assay for non-transferrin-bound iron (NTBI) is reproducible and specific, detecting iron only at high transferrin saturation. This assay measures a smaller portion of NTBI compared to chelation methods.
Area of Science:
- Clinical Chemistry
- Hematology
- Analytical Biochemistry
Background:
- Non-transferrin-bound iron (NTBI) plays a role in iron overload disorders.
- Accurate measurement of NTBI is crucial for patient management.
- Existing methods for NTBI determination have limitations.
Purpose of the Study:
- To evaluate a microwell modification of the bleomycin assay for NTBI determination.
- To compare this modified assay with a standard chelation method.
- To assess the specificity and reproducibility of the bleomycin assay for NTBI.
Main Methods:
- A microwell adaptation of the bleomycin assay was developed, halving reagent and sample volumes.
- NTBI was measured in patient samples from hematologic malignancy treatments.
- Comparison involved a chelation-based method, transferrin saturation, and iron distribution analysis.
Main Results:
- The microwell bleomycin assay demonstrated good reproducibility (CVs 7.7-18%).
- NTBI was detected only when transferrin saturation exceeded 80%, indicating high specificity.
- The bleomycin assay yielded lower NTBI concentrations than the chelation method, with lower iron recovery.
Conclusions:
- The microwell bleomycin assay is a reproducible method for NTBI measurement.
- The assay shows high specificity, detecting NTBI primarily at high transferrin saturation (>80%).
- Bleomycin-detectable iron represents a subset of total NTBI measured by chelation methods.